Skip to main content

Ciprofloxacin

 

1. Generic & Brand Names

  • Generic: Ciprofloxacin HCl

  • Brands: Cipro® (Global), Ciloxan® (ophthalmic), Proquin® XR (ER)

  • Formulations:

    • Tablets (100mg, 250mg, 500mg, 750mg)

    • Extended-release (500mg, 1000mg)

    • IV infusion (200mg/100mL, 400mg/200mL)

    • Oral suspension (250mg/5mL, 500mg/5mL)

2. Drug Class & Mechanism

  • Class: Fluoroquinolone antibiotic (2nd generation)

  • Mechanism: Inhibits DNA gyrase & topoisomerase IV → bactericidal

  • Spectrum:

    • Gram-negative: E. coli, P. aeruginosa, Salmonella, Shigella, Campylobacter

    • Gram-positive: Limited (not for MRSA/penicillin-resistant Strep)

3. FDA-Approved Uses

Infection TypeKey PathogensFirst-Line?
Complicated UTIE. coli, K. pneumoniaeAlternative
Acute PyelonephritisP. aeruginosa (suspected)Yes
ProstatitisEnterobacteriaceaeFirst-line
Infectious DiarrheaCampylobacter, ShigellaSevere cases only
Typhoid FeverS. typhi (MDR strains)Yes

⚠️ Restricted Use (FDA 2016/2018):

  • Reserved for infections with no alternative options due to severe safety risks.

  • Avoid for uncomplicated UTIs, sinusitis, bronchitis.

4. Dosing Regimens

Infection TypeAdult DoseDuration
Uncomplicated UTI250 mg PO q12h3 days
Complicated UTI/Pyelonephritis500 mg PO q12h OR 400 mg IV q12h7-14 days
Acute Prostatitis500 mg PO q12h28 days
Infectious Diarrhea500 mg PO q12h5-7 days
Renal Dose Adjustment: ↓ by 50% if CrCl <30 mL/min

Key Administration Notes:

  • Take PO 2h before/6h after antacids/Ca²⁺/Fe²⁺/Zn²⁺ (chelation ↓ absorption)

  • Hydrate well → prevents crystalluria

  • IV Infusion: Administer over 60 min (rapid infusion → hypotension)

5. Black Box Warnings (FDA)

  1. Tendon Rupture:

    • Risk ↑ in >60 yrs, steroid users, organ transplant

    • May occur months after treatment; discontinue at first sign of pain/swelling

  2. Peripheral Neuropathy:

    • Irreversible nerve damage (pain/burning/weakness)

  3. CNS Effects:

    • Seizures, psychosis, suicidal thoughts

  4. Exacerbates Myasthenia Gravis:

    • Avoid in patients with MG → respiratory failure risk

6. Side Effects

Common (≥10%)Serious (Discontinue Immediately)
Nausea/vomitingTendon rupture (Achilles>shoulder)
DiarrheaQT prolongation → Torsades
HeadacheAortic aneurysm/dissection
RashHypersensitivity (anaphylaxis)
PhotosensitivityC. difficile colitis

7. Critical Drug Interactions

MedicationRiskAction
Theophylline↑ Levels → seizures/tachycardia↓ Theophylline dose 30%
Warfarin↑ INR → bleedingMonitor INR daily
Corticosteroids↑ Tendon rupture riskAvoid combo
Antidiabetics↑ Hypoglycemia (glyburide/insulin)Monitor glucose

8. Resistance & Stewardship

  • Resistance Rising:

    40% E. coli UTIs in US show fluoroquinolone resistance (IDSA 2023)

  • When to Avoid:

    • Uncomplicated cystitis (use nitrofurantoin/fosfomycin)

    • Community-acquired pneumonia (no Strep coverage)

    • Gram-positive infections (use TMP-SMX/β-lactams)

9. Pediatric Use

  • Contraindicated for routine infections in children (cartilage damage risk)

  • Exceptions:

    • Complicated UTIs/pyelonephritis (≥1 yr)

    • Anthrax exposure

    • Dose: 10-20 mg/kg IV q12h (max 400 mg/dose)

10. Storage & Handling

  • Tablets: 15-30°C (59-86°F); protect from light

  • Oral Suspension:

    • Refrigerate (2-8°C/36-46°F)

    • Discard after 14 days

  • IV Solution: Discard unused portions

Clinical Practice Guidelines

✅ Appropriate Use:

  • Pyelonephritis with suspected Pseudomonas

  • Traveler's diarrhea (severe/Campylobacter)

  • Chronic bacterial prostatitis
    ❌ Avoid For:

  • Uncomplicated UTIs, strep throat, viral infections

  • Patients with tendon disorders or CNS disease

⚠️ Mandatory Patient Counseling:

  • "Stop drug and call MD immediately for tendon pain/mood changes."

  • "Avoid sun exposure (use SPF 50+)."

  • "Do not take with dairy/antacids/vitamins."

Alternatives to Ciprofloxacin

InfectionPreferred Agents
Uncomplicated UTINitrofurantoin, Fosfomycin
GI InfectionsAzithromycin (Campylobacter), Ceftriaxone (Shigella)
PyelonephritisCeftriaxone, Ertapenem

📊 Efficacy Data:

  • Complicated UTI cure rate: 78% vs. 82% for ceftriaxone (CID 2022)

  • Resistance in E. coli UTIs: 42% US, >60% Asia (WHO 2023)

Prescribing Status: Restricted in US/EU; requires prior authorization for non-approved indications. Report adverse events to FDA MedWatch.

Comments

Post a Comment

Popular posts from this blog

First-Year BPT Study Guide: Units 1 to 4 Explained for Physiotherapy Students

  🔹 Introduction Starting your Bachelor of Physiotherapy (BPT) journey? The first year lays the essential groundwork for becoming a skilled physiotherapist. This blog explains the first-year BPT Units 1 to 4—key concepts that cover physiotherapy basics, anatomy, physiology, and professional ethics. Whether you're studying for exams or building your foundation, these insights are crucial for academic and clinical success. 🔹 Unit 1: Introduction to Physiotherapy Keywords: introduction to physiotherapy, first-year physiotherapy course, BPT basics In this unit, students explore the history, scope, and branches of physiotherapy. From treating joint pain to supporting neurological rehabilitation, physiotherapy offers diverse career opportunities. The profession originated in ancient times and gained formal recognition during wartime rehabilitation. Specialties include: Orthopedic physiotherapy Neurological physiotherapy Pediatric physiotherapy Cardiopulmonary physiot...
Post a Comment
Read more

⚠️ Contraindications of Electrotherapy Modalities: Learn Fast

  Electrotherapy is a powerful tool in physiotherapy — but using it safely is just as important as using it effectively. Here's a fast-track guide to the contraindications of common electrotherapy modalities for students, interns, and clinicians. 🚫 What Are Contraindications? These are conditions or situations where electrotherapy should NOT be used due to risk of harm or complications. ⚡ Common Electrotherapy Modalities & Their Contraindications 🔌 1. TENS (Transcutaneous Electrical Nerve Stimulation) Avoid if: Patient has a pacemaker or implantable defibrillator Over pregnant abdomen or uterus Over malignant tumors Broken, infected, or anesthetic skin On carotid sinus area (risk of cardiac reflex) Epileptic patients (caution advised) 🔄 2. IFT (Interferential Therapy) Avoid if: Metal implants in the treatment area Open wounds or skin conditions Pregnancy (especially lower abdomen/lumbar) Over the eyes, carotid sinus, or chest...
Post a Comment
Read more

Metoprolol – heart rate control

  1.  Mechanism & Class Class:  β₁-Selective Beta-Blocker ( Cardioselective ) Action: Blocks cardiac β₁-receptors → ↓  sinus node firing rate  and  AV conduction Reduces resting/peak heart rate (HR), myocardial oxygen demand Formulations: Tartrate (IR):  Short-acting (dosed BID) -  Lopressor® Succinate (ER):  24-hour control -  Toprol-XL® 2.  Key Indications for Rate Control Condition Target HR Formulation Atrial Fibrillation (AFib) 60-100 bpm Tartrate BID Sinus Tachycardia 60-100 bpm Succinate daily Post-MI Tachycardia 50-60 bpm Tartrate BID → Succinate SVT Acute IV → PO IV/PO Tartrate 3.  Dosing Protocols Scenario Initial Dose Titration Max Dose Chronic AFib Tartrate 25 mg BID ↑ by 25 mg BID q3-7d 100 mg BID Acute SVT/AFib (IV) 2.5-5 mg IV slow Repeat q5min × 3 15 mg Post-MI Tartrate 25 mg BID → Switch to Succinate 100 mg daily 200 mg/day Anxiety-Induced Tachycardia Succinate 25 mg daily ↑ 25 mg weekly 200 mg/day Goal HR:...
Post a Comment
Read more